Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR | Q13258 | 3/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 8/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7433243 | 0.80 | FFAR1 (0.50) | PTGDR2FFAR1MAPTTDP1 | |
| SCHEMBL32689796 | 0.75 | PTGDR (0.59) | PTGDRPTGDR2FFAR1MAPTFFAR4 | |
| SCHEMBL19522397 | 0.73 | KMT2A (0.49) | PTGDRFFAR1MAPTFFAR4CHRM1 | |
| SCHEMBL5458601 | 0.71 | ABL1 (0.54) | FFAR1FFAR4NPSR1 | |
| SCHEMBL7412627 | 0.71 | FFAR4 (0.50) | FFAR1MAPTFFAR4CHRM1TDP1 | |
| SCHEMBL8239091 | 0.71 | PLAU (0.47) | FFAR1MAPTFFAR4TDP1NPSR1 | |
| SCHEMBL5500307 | 0.71 | SMN1; SMN2 (0.53) | FFAR1FFAR4NPSR1TSHR | |
| SCHEMBL1418003 | 0.71 | HIF1A (0.59) | FFAR1MAPTFFAR4NPSR1 | |
| SCHEMBL32689799 | 0.71 | FFAR1 (0.49) | FFAR1MAPTFFAR4TDP1NPSR1 | |
| SCHEMBL4699761 | 0.71 | FFAR1 (0.49) | FFAR1MAPTFFAR4TDP1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712969-A1 | CYCLIN INHIBITORS | Circle Pharma, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |